Latest News- Bio-Pharma Market: Monoclonal antibodies is expected to lead the Product segment during 2025-2029

The Bio-Pharma Market is being driven by Increasing prevalence of health disorders

The Bio-Pharma Market is expected to grow at a CAGR of 9% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 311.8 billion. In the Bio-Pharma sector, vaccines represent a crucial investment in preventative healthcare. These immunizations offer cost-effective solutions against infectious diseases such as diphtheria, Hepatitis B, and measles. Despite their benefits, approximately 15%-20% of infants worldwide remain unimmunized, leading to unnecessary deaths, particularly in developing regions like Africa and South America. Key challenges include insufficient awareness and vaccine production capacity. However, initiatives like the World Health Organization's National Immunization Program (NIP) aim to address these issues, promoting disease prevention, reducing mortality, and enhancing global health. 

Get more information on Bio-Pharma Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Monoclonal antibodies
  • Recombinant growth factors
  • Vaccines
  • Recombinant hormones
  • Others
• Application
  • Oncology
  • Autoimmune disorder
  • Metabolic disorder
  • Hormonal disorder
  • Others
• Drug Class
  • Proprietary biologics
  • Biosimilars
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing prevalence of health disorders
• Growing geriatric population
• Targeted therapeutic mechanism of biologics

However, the market also witnesses some limitations, which are as follows:

• High cost of bio-pharmaceuticals
• Changing formulations in product design
• Issues related to entry of new bio-pharmaceuticals

Benefits of Buying Global Bio-Pharma Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Bio-Pharma Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Bio-Pharma industry is witnessing significant changes with the emergence of biosimilars, which are affordable alternatives to original biologic drugs. Key aspects include biosimilar substitution and interchangeability, pricing, competition, market share, adoption, access, regulatory landscape, patent landscape, litigation, manufacturing capabilities, analytical methods, quality attributes, efficacy, safety, immunogenicity, pharmacokinetics, pharmacodynamics, bioavailability, clinical trials, patient outcomes, value proposition, market potential, growth prospects, and investment opportunities. These factors shape the future of the biosimilar market.

Market Research Overview

In the dynamic landscape of the global biopharmaceutical industry, key sectors include biotechnology manufacturing, specifically therapeutic antibodies, gene therapy, and cell therapy, as well as the production of recombinant proteins. The parent market, encompassing pharmaceuticals, is projected to expand significantly due to several drivers. One major factor is the increasing global population aging, with the proportion of individuals over 60 years old in the US projected to reach approximately 25% by 2050, and Europe projected to reach a similar ratio by 2030. This demographic shift will fuel demand for healthcare solutions, including advanced biopharmaceutical treatments. According to market analysis by Technavio, the global healthcare market size is determined by the combined revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. This market growth is anticipated to be driven by the increasing aging population, as well as advancements in technology and research and development in the biopharmaceutical sector.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/